The ability to determine who will recover quickly, and who will continue to suffer from symptoms has largely eluded the medical community. Until now.
A world-first international study led by the University of South Australia has identified a new drug to stop athletes developing dementia after sustaining repeated head injuries in their career.
A neurologic pathway by which non-damaging but high frequency brain impact blunts normal brain function and causes long-term problems with learning and memory has been identified. The finding suggests that tailored drug therapy can be designed and developed to reactivate and normalize cognitive function, say neuroscientists at Georgetown University Medical Center.
As part of nationwide study to improve trauma care for severe brain injuries, researchers at UChicago Medicine are working to engage South Side residents and ensure representation among underrepresented communities.
The authors have created a simple and practical tool for use in assessing impaired consciousness in the clinical setting when the verbal component of the Glasgow Coma Scale is missing.
ASU sociologist finds team-oriented exercises benefit us socially and can also increase life span